CAS 935283-04-8

Formel: C22H15F3N2O7S

InChl: InChI=1S/C22H15F3N2O7S/c1-32-14-4-3-10(23)18(25)9(14)7-34-16-6-13(11(24)5-15(16)33-2)27-20(28)17-12(26-22(27)31)8-35-19(17)21(29)30/h3-6,8H,7H2,1-2H3,(H,26,31)(H,29,30)

InChI Key: BMAAMIIYNNPHAB-UHFFFAOYSA-N

SMILES: COC1=C(C(=C(C=C1)F)F)COC2=C(C=C(C(=C2)N3C(=O)C4=C(SC=C4NC3=O)C(=O)O)F)OC

Linzagolix

CAS: 935283-04-8

Linzagolix

Formel: C₂₂H₁₅F₃N₂O₇S

Reinheit: ≥98%

Molekulargewicht: 508.42

Ref: 54-BUP02769

Linzagolix

CAS: 935283-04-8

Formel: C₂₂H₁₅F₃N₂O₇S

Molekulargewicht: 508.42

Ref: 4Z-L-232001

3-(5-((2,3-Difluoro-6-methoxybenzyl)oxy)-2-fluoro-4-methoxyphenyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-5-carboxylic acid

CAS: 935283-04-8

Formel: C₂₂H₁₅F₃N₂O₇S

Reinheit: 98%

Molekulargewicht: 508.4239

Ref: IN-DA01XDI8

Linzagolix

CAS: 935283-04-8

Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei

Formel: C₂₂H₁₅F₃N₂O₇S

Reinheit: 99.33% - 99.95%

Farbe und Form: White Solid

Molekulargewicht: 508.424

Ref: TM-T27837

Linzagolix

CAS: 935283-04-8

3-(5-((2,3-Difluoro-6-methoxybenzyl)oxy)-2-fluoro-4-methoxyphenyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[3,4-d]pyrimidine-5-carboxylic acid

Formel: C₂₂H₁₅F₃N₂O₇S

Reinheit: 98%

Molekulargewicht: 508.42

Ref: IN-DG01471526